Breast implant revision surgery: indications and complication rates

How the evidence was selected: PubMed criteria for the latest meta-analyses

A targeted PubMed search strategy was applied to identify recent systematic reviews and meta-analyses related to complications, revision indications and outcomes after implant-based breast surgery. Priority was given to studies with pooled quantitative analysis, published between 2023 and 2025, and with direct or indirect relevance to breast implant revision surgery.

The final selection includes five PubMed-indexed publications: a 2025 meta-analysis on capsular contracture after breast augmentation, a 2024 meta-analysis on capsular contracture in breast reconstruction, a 2023 meta-analysis on complications in prepectoral versus subpectoral direct-to-implant reconstruction, a 2025 meta-analysis on breast implant illness symptoms and a 2025 meta-analysis on the prevalence of BIA-ALCL in patients with textured implants.

Main indications for breast implant revision surgery

The indications for breast implant revision surgery vary according to the aesthetic, reconstructive or clinical setting. The most common include:

• Capsular contracture, especially when it causes pain, stiffness or breast deformity.
• Malposition, asymmetry or aesthetic dissatisfaction, when the result is not stable or harmonious.
• Rupture, suspected rupture or local implant complications such as seroma, infection or implant exposure.
• Systemic symptoms reported by the patient, compatible with breast implant illness after exclusion of other causes.
• Suspicious late signs, such as persistent seroma, capsular mass or sudden breast enlargement.

Capsular contracture: The main structural indication for revision

Capsular contracture is an excessive fibrotic response around the breast implant. When the capsule becomes rigid or painful, it may deform the breast and require capsulectomy, capsulotomy, implant replacement or implant plane change. A 2025 meta-analysis evaluated how implant characteristics and surgical technique influence capsular contracture rates after breast augmentation; the study reported that textured implants were associated with lower rates of capsular contracture compared with smooth implants in the analyzed context.

However, this finding must be interpreted with clinical caution. Implant surface selection cannot be based only on capsular contracture, because textured implants are also central to discussions regarding BIA-ALCL risk. Therefore, during pre-revision counseling, reducing one local risk must be balanced against the overall implant safety profile, the patient’s history and updated regulatory and oncologic recommendations.

Capsular contracture in breast reconstruction: A more complex risk profile than primary aesthetic surgery

In implant-based breast reconstruction, capsular contracture represents a more complex issue than in primary aesthetic breast augmentation. Reconstructed patients may have more vulnerable tissues, oncologic history, mastectomy, radiotherapy, use of acellular dermal matrices or the need for multiple surgical stages. A 2024 meta-analysis included 23 studies and evaluated factors such as implant type, implant surface and placement plane in capsular contracture after breast reconstruction.

From a practical perspective, this evidence suggests that revision in reconstructive settings is not simply implant replacement. It may require pocket correction, capsule treatment, management of irradiated tissues, possible use of biological or synthetic support materials and assessment of skin stability. Reconstructive revision should therefore be considered a procedure with a more complex risk profile than simple aesthetic revision.

Reoperation and complications after direct-to-implant reconstruction

The 2023 meta-analysis compared prepectoral and subpectoral direct-to-implant breast reconstruction across 18 studies, 2,360 patients and 3,135 breasts. Prepectoral reconstruction was associated with lower odds of hematoma, seroma, infection, revision/reoperation and animation deformity. Revision risk was reduced compared with the subpectoral group, with an OR of 0.44, while animation deformity showed a more marked reduction, with an OR of 0.01.

This finding is relevant because many revisions depend not only on the implant itself, but also on the implant plane. Malposition, dynamic deformity, pain, asymmetry or local complications may require pocket revision, plane conversion or implant replacement.

Breast implant illness as an emerging indication for explantation or revision

The 2025 meta-analysis included 36 articles and 10,519 patients, comparing symptoms reported by women with and without breast implants. The symptoms most associated with implant presence included fatigue, weakness and cognitive dysfunction. The study also reported a stronger association between symptoms compatible with breast implant illness and ruptured implants or silicone implants. Patients who underwent explantation reported fewer symptoms, but this finding does not demonstrate an automatic causal relationship in every individual case.

From a clinical perspective, BII represents an emerging indication for revision or explantation when systemic symptoms are persistent and clinically significant for the patient. Counseling should remain balanced: symptoms should not be ignored, but they should not automatically be attributed to the implant. A systematic evaluation is necessary, including exclusion of other medical causes and realistic discussion of the possible benefits and limitations of the available evidence.

BIA-ALCL: Rare, but highly impactful in revision decision-making

BIA-ALCL is a rare complication mainly associated with textured implants, but it may directly influence revision decisions. The 2025 meta-analysis by Ward et al. estimated a prevalence of 30.54 cases per 100,000 patients, corresponding to approximately 1 case per 3,274 patients with textured implants. A 2024 meta-analysis confirmed the association between breast implants and ALCL in both aesthetic and reconstructive settings. For this reason, late signs such as persistent seroma, sudden breast enlargement, capsular mass or local changes require specific evaluation. BIA-ALCL does not justify generalized alarmism, but in the presence of suspicious findings, revision should not be treated as a purely aesthetic procedure: it becomes part of a specialized diagnostic and therapeutic pathway.

Clinical implications for pre-revision counseling

Pre-revision counseling should frame the procedure as an individualized corrective intervention, not as simple implant replacement. The consultation should clarify:

• Indication for revision: capsular contracture, implant rupture, malposition, reported systemic symptoms or clinically relevant suspicion.
• Goal of surgery: pain reduction, deformity correction, symmetry improvement, implant replacement or explantation.
• Proposed procedure: implant replacement, capsulectomy, capsulotomy, pocket revision or implant plane change.
• Residual risk: recurrence of capsular contracture, infection, seroma, malposition or need for further revisions.
• Limitations of the result: especially in the presence of thin, irradiated, compromised tissues or tissues already subjected to multiple procedures.
• Clinical follow-up: monitoring for late seroma, persistent pain, sudden breast enlargement, capsular mass or local alterations.

Evidence-based summary

The most recent PubMed meta-analyses indicate that:

• Capsular contracture remains one of the main indications for breast implant revision surgery.
• Revision risk varies according to the clinical setting, with a more complex profile in reconstructed patients compared with primary aesthetic surgery.
• Local complications such as infection, seroma, hematoma, malposition, dynamic deformity or need for explantation may contribute to reoperation.
• Systemic symptoms reported by the patient, compatible with breast implant illness, represent an emerging indication for evaluation for explantation or revision.
• BIA-ALCL is rare but clinically relevant, especially in the presence of late seroma, capsular mass or sudden breast enlargement.
• Revision should not be interpreted as simple implant replacement, but as an individualized procedure for correction and risk management.

Bibliography: The five PubMed-indexed meta-analyses considered

- Haas E. Capsular Contracture After Breast Augmentation: A Systematic Review and Meta-Analysis. Aesthetic Surgery Journal Open Forum. 2025. PMID: 39989707.

- Christodoulou N. Capsular Contracture in Breast Reconstruction: A Systematic Review and Meta-Analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2024. PMID: 39244792.

- Montorfano L. Examination of Outcome Disparities in Reports of Prepectoral and Subpectoral Direct-to-Implant Reconstruction: A Systematic Review and Meta-analysis. Annals of Plastic Surgery. 2023. PMID: 36975095.

- Bouhadana G. Defining Breast Implant Illness: A Systematic Review and Meta-analysis of Patient-reported Symptoms. Plastic and Reconstructive Surgery Global Open. 2025. PMID: 40391348.

- Ward JA. Estimating the Prevalence of Breast Implant-Associated Anaplastic Large Cell Lymphoma. 2025. PMID: 39331823.